IS DRUNK AND HAS LOST HER BROOMSTICK
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Opko Health
Opko Health Inc.’s (NASDAQ: OPK) short interest increased more than 2% from in the previous period to almost 66.70 million shares on the most recent settlement date. That was the greatest level of short interest so far this year, and it represented 20.4% of the total float. At the latest daily average trading volume, a year to date low, the days to cover figure was more than 16.
For well more than a year, the CEO frequently has bought batches of Opko shares. The stock closed most recently at $3.00 a share, in a 52-week trading range of $2.66 to $7.90. By the end of the two-week short-interest period, the share price was a more than 5% lower, despite being up about 5% at one point. The stock currently is down more than 39% since the beginning of the year.
https://247wallst.com/investing/2018/04/25/the-6-most-shorted-nasdaq-stocks-comcast-on-the-rise/2/
Opko Health Inc (NASDAQ:OPK) down -0.33% to close at the price of $3. The stock has a market capitalization of $1.75 Billion however its outstanding shares are 584.9 Million. The company’s beta value stood at 1.58.
Opko Health Inc (NASDAQ:OPK) has an ABR of 2.2 which is the combined stock view of 5 analysts poll results. As per Zacks simplified descending rating scale the ABR rank is displayed in the range of 1 to 5 where 1 represents Strong Buy and 5 a Strong Sell. As the name implies that ABR will show you the Average of Brokerage Recommendations on a given stock. It helps you quickly get a picture of where Wall Street stands on a stock without reading huge research reports. The smaller number of ABR is the more favorable. The modest value of the stock is known as the current ABR of the stock.
However out of 5 analysts 1 suggest Opko Health Inc (NASDAQ:OPK) a Strong Buy, 3 suggested Buy, 1 Hold and 1 Sell, while 0 analysts recommend the stock a Strong Sell.
Analysts are expecting average earnings estimates of $-0.13 for the current quarter based on the opinion of 5 analysts, relating to high earnings per share estimates of $-0.1 and low estimates of $-0.16, however Opko Health Inc (NASDAQ:OPK) reported $-0.06 earnings per share for the same quarter last year.
For the current quarter Opko Health Inc (NASDAQ:OPK) has average revenue estimates of $236.9 Million, a total number of 5 analysts provided estimations over revenues. However the low revenue estimates for the company are $197.6 Million versus high revenue estimates of $253 Million. A year ago the company’s sales were $296100 while its sales growth yearly estimates for the current quarter are -20%.
Taking a broader look at the analyst consensus, brokerage firms have a price target of $11.9 on Opko Health Inc (NASDAQ:OPK). Brokerage firms on the street have price targets on the name ranging from $3.5 to $20 based on 5 opinions.
Opko Health Inc (NASDAQ:OPK) as of current trade, has shown weekly performance of -3.54% which was maintained at -8.26% in one month period. Year to date performance remained at -38.78%. During the past three months the stock gain -37.89%, however six months performance of the stock remained at -56.9%. Opko Health Inc (NASDAQ:OPK)’s price sits -11.1% off from its SMA 50 of $3.23 and -42.23% away from the SMA 200 which is at $4.65.
Currently Opko Health Inc (NASDAQ:OPK)’s shares owned by insiders are 1.6%, whereas shares owned by institutional owners are 24.2%. However the six-month change in the insider ownership was recorded 43.76%, as well as three-month change in the institutional ownership was recorded 0.44%.
The stock is trading -62.01% away from its 52 week high of $7.90 and 12.78% far from the stock’s low point over the past 52 weeks, which was $2.66.
The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings. Opko Health Inc (NASDAQ:OPK)’s price to earnings ratio stood at 0. A high P/E suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E. A low P/E can indicate either that a company may currently be undervalued or that the company is doing exceptionally well relative to its past trends.
The PEG ratio is used to determine a stock’s value while taking the company’s earnings growth into account, and is considered to provide a more complete picture than the P/E. Opko Health Inc (NASDAQ:OPK) has a current PEG of 0. Opko Health Inc (NASDAQ:OPK)’s price to sales ratio for trailing twelve month stands at 1.64, whereas its price to book ratio for the most recent quarters is at 0.89. However the company’s price to cash per share for most recent quarter stands at 0. Its price to free cash flow for trailing twelve months is 0.
https://emnnews.com/2018/04/25/experts-analysis-opko-health-inc-opk-2/
The thing I am concerned about is how much of the network will be transfered to CCGI I am going to call Brian today..
On May 30, 2013, JNS Power & Control Systems, Inc. (“JNS”) filed a complaint against 350 Green, LLC alleging claims for breach of contract, specific performance and indemnity arising out of an Asset Purchase Agreement between JNS and 350 Green entered on April 13, 2013, whereby JNS would purchase car chargers and related assets from 350 Green. On September 24, 2013, the District Court entered summary judgment in favor of JNS on its claim for specific performance. On September 9, 2015, the United States Court of Appeals for the Seventh Circuit of Chicago, Illinois affirmed the ruling of the District Court, which affirmed the sale of certain assets by 350 Green to JNS and the assumption of certain 350 Green liabilities by JNS. On April 7, 2016, JNS amended the complaint to add the Company, alleging an unspecified amount of lost revenues from the chargers, among other matters, caused by the defendants. Plaintiff also seeks indemnity for its unspecified attorney’s fees and costs in connection with enforcing the Asset Purchase Agreement in courts in New York and Chicago. On July 26, 2017, the District Court denied the Company’s motion to dismiss the Company from the suit. The Company answered the second amended complaint on August 16, 2017. The deadline for the parties to complete discovery is December 8, 2017. The next status hearing on the matter is set for December 8, 2017. As of September 30, 2017, the Company accrued a $750,000 liability in connection with its settlement offer to JNS. The parties are in the process of documenting a settlement.
already there
The Electric Revolution Is About To Upend Transportation
https://www.huffingtonpost.com/entry/the-electric-revolution-is-about-to-upend-transportation_us_59ea75d1e4b092f9f241920f
doing good..still way long..haven't sold a single share..
Recent launches in the renal market have typically been associated with slow uptake, largely hampered by limited market access. This is also true for Opko's Rayaldee, a vitamin D3 prohormone launched in November 2016. However, Opko also faces other challenges as well, including an inferior promotional rate (compared to phosphate binders and Sensipar), low familiarity among nephrologists, and a lack of a perceived unmet need for the product. Indeed, just 6% of the surveyed nephrologists reported any trial of Rayaldee at the four month mark and two-thirds have not had any contact with a sales representative since the product was launched.
https://goo.gl/xUIOfW
Still holding tight..KF
June did her part...
If you have decided to sell..and the arrival of wolves concern you..sell while there are still buyers
I am fairly sure there are no restricted shares..all are free trading..
I had that thought also
The charge is on for more electric cars in New Jersey
https://goo.gl/G4zima
Study: Benefits of Electric Cars Add Up—in the Billions!
https://goo.gl/6NFRpG
Electric Cars Will Get Big Boost From Rules Curbing Conventional Ones-Report
https://goo.gl/gpHCGm
Hyundai announces 4 new all-electric cars by 2020
https://goo.gl/vevSJn
Jaguar's New Electric SUV is a Crazy-Fast Tesla Model X Clone
https://goo.gl/MaSxQc
Lucid Motors Unveils Its Top-Secret 1000 Horsepower Electric Car
https://goo.gl/PXIKsR
Motor Trend taps GM's electric vehicle as Car of the Year
https://goo.gl/Ydy4G4
Tesla may get all the buzz, but GM has the first electric car with a 200-mile range that costs less than $40K
https://goo.gl/rdjd5Z
Why Carmakers Are Gearing Towards Electric Cars Even When Cheap Gasoline Is Available
https://goo.gl/6VMpl0
Intel Courts Autonomous Car Makers -- 2nd Update
https://goo.gl/RrI72Q
About this I asked Brian about this when I called him some time ago and he told me that by the time a final cost was arrived at it was more than he could spend because the funds were needed on a project elsewhere..I usually call 3-4 times a year..I have also been told that his legal team advised him to refrain from publicly releasing any news regarding the ongoing legal action without consulting them first..read anything you want into this post..and take it from there..what some people fail to understand in a business as future and present conditions can change quite often and it evolves to meet them
we'll see
that gives the group at least 135M
how many do you think the FB group holds all combined
Area electric vehicle charging stations seeing usage
https://goo.gl/OcMdY6
Hyundai's electric car strategy takes shape under the radar
https://goo.gl/3aWzhp
Faraday Future teases new electric car for CES 2017
https://goo.gl/1GjuQI
US Plans 25000-Mile Network for Electric Cars Covering 35 States
https://goo.gl/ERBLoY
19 long-range electric cars you'll be able to drive by 2021
https://goo.gl/MxJHDW
Administration Gives Electric Car Charging Grid A Boost
https://goo.gl/Tx0jCs
Well I joined..
New plans proposed for more electric vehicle chargepoints
https://goo.gl/CkY4bJ
Mercedes just unveiled its all-electric SUV concept car, the Generation EQ
https://goo.gl/qA3ulm
Mercedes-Benz Plan to Win the Electric Cars Game
https://goo.gl/smTyG8
Why Audi Is Quitting Le Mans to Focus on Electric Car Racing
https://goo.gl/Qrrr0T
GM is expected to sell more than 30000 Bolt electric cars
https://goo.gl/Ksdmj1
Here you go..hope this helps..